Difference between revisions of "Team:Reading/Experiments"

Line 8: Line 8:
 
<p>The process involved inoculating a single conical flask containing BG-11 medium with both the wild type and triple mutant to see which would survive in the flask and outcompete the other strain. This would be shown by then attempting to grow a loop of culture on kanamycin agar plates. This is used as the triple mutant contains the genes for kanamycin resistance, as is present on the plasmid whereas the wild type is susceptible to kanamycin as it lack the genes required for resistance and so would not grow on kanamycin resistance plates. The growth on the kanamycin plates (measured in colony forming units per ml (cfu/ml)) is then compared to the growth on a BG-11 plate without kanamycin, which gives an indication of the total number of cfu/ml from the culture. This gives an indication of which strain outcompeted the other.</p>
 
<p>The process involved inoculating a single conical flask containing BG-11 medium with both the wild type and triple mutant to see which would survive in the flask and outcompete the other strain. This would be shown by then attempting to grow a loop of culture on kanamycin agar plates. This is used as the triple mutant contains the genes for kanamycin resistance, as is present on the plasmid whereas the wild type is susceptible to kanamycin as it lack the genes required for resistance and so would not grow on kanamycin resistance plates. The growth on the kanamycin plates (measured in colony forming units per ml (cfu/ml)) is then compared to the growth on a BG-11 plate without kanamycin, which gives an indication of the total number of cfu/ml from the culture. This gives an indication of which strain outcompeted the other.</p>
 
<p>The design of the experiment is as follows, observe aseptic technique throughout, 6803 refers to Synechocystis sp. PCC 6803:  
 
<p>The design of the experiment is as follows, observe aseptic technique throughout, 6803 refers to Synechocystis sp. PCC 6803:  
−
<ul>
+
<ol>
 
<li>Add  approx. 200ml of BG-11 medium to a sterile conical flask.</li>
 
<li>Add  approx. 200ml of BG-11 medium to a sterile conical flask.</li>
 
<li>Inoculate flask with 10µl of stock Wild type 6803, and 10µl of stock mutant 6803.</li>
 
<li>Inoculate flask with 10µl of stock Wild type 6803, and 10µl of stock mutant 6803.</li>
Line 15: Line 15:
 
<li>Estimate the colony forming units per ml (cfu/ml) on each plate.</li>
 
<li>Estimate the colony forming units per ml (cfu/ml) on each plate.</li>
 
<li>The difference in cfu/ml on each plate will give an indication of which strain of 6803, wild type or mutant, will out-compete the other when placed in the same environment.</li>
 
<li>The difference in cfu/ml on each plate will give an indication of which strain of 6803, wild type or mutant, will out-compete the other when placed in the same environment.</li>
−
</ul>
+
</ol>
 
  </p>
 
  </p>
 
<hr>
 
<hr>
 
<p><h5>Ferricyanide assay to measure electron output of various strains of <i>Synechocystis sp. PCC 6803</i></h5></p>
 
<p><h5>Ferricyanide assay to measure electron output of various strains of <i>Synechocystis sp. PCC 6803</i></h5></p>
 
<p>[Fe(CN)<sub>6</sub>]<sup>3-</sup> + e<sup>-</sup> ⇌ [Fe(CN)<sub>6</sub>]<sup>4-</sup></p>
 
<p>[Fe(CN)<sub>6</sub>]<sup>3-</sup> + e<sup>-</sup> ⇌ [Fe(CN)<sub>6</sub>]<sup>4-</sup></p>
−
<p><ol>
+
<p><ul>
 
<li>Ferricyanide is a complex ion composed of an Fe<sup>3+</sup>  ion chelated by six CN- ions, which has an octahedral geometry, and a net charge of 3-.</li>
 
<li>Ferricyanide is a complex ion composed of an Fe<sup>3+</sup>  ion chelated by six CN- ions, which has an octahedral geometry, and a net charge of 3-.</li>
 
<li>Treatment of the ferricyanide ion with ferrous salts gives Prussian Blue (pigment)</li>     
 
<li>Treatment of the ferricyanide ion with ferrous salts gives Prussian Blue (pigment)</li>     
Line 26: Line 26:
 
<li>Ferricyanide oxidised by Fe3+ in the presence of Ferene-S (acidic conditions)</li>
 
<li>Ferricyanide oxidised by Fe3+ in the presence of Ferene-S (acidic conditions)</li>
 
<li>Chromogenic Ferene-S/Fe<sup>2+</sup> complex is formed upon reduction, which has a net 4- charge.</li>
 
<li>Chromogenic Ferene-S/Fe<sup>2+</sup> complex is formed upon reduction, which has a net 4- charge.</li>
−
</ol>
+
</ul>
 
<hr>
 
<hr>
 
<p><h5>Public perception and awareness study: Methods and Questionaire</h5></p>
 
<p><h5>Public perception and awareness study: Methods and Questionaire</h5></p>

Revision as of 11:59, 25 August 2015

Experiments

This section documents the designs and protocols for experiments we carried out during our project

Competition assay

The aim of the competition assay was to determine which bacteria strain, either triple mutant or wild type was fitter and therefore more able to compete for nutrients and resources. This gives us an indication of how one strain may grow compared to another and to see the impact of the modifications made to the mutant strain. This also allows us to consider the safety of the use of the mutant, by providing insight into how well the mutant bacteria can survive in normal conditions if released into the wild when competing against wild type bacteria. This would allow us to consider the potential impacts of the accidental release of the mutant on the environment.

The process involved inoculating a single conical flask containing BG-11 medium with both the wild type and triple mutant to see which would survive in the flask and outcompete the other strain. This would be shown by then attempting to grow a loop of culture on kanamycin agar plates. This is used as the triple mutant contains the genes for kanamycin resistance, as is present on the plasmid whereas the wild type is susceptible to kanamycin as it lack the genes required for resistance and so would not grow on kanamycin resistance plates. The growth on the kanamycin plates (measured in colony forming units per ml (cfu/ml)) is then compared to the growth on a BG-11 plate without kanamycin, which gives an indication of the total number of cfu/ml from the culture. This gives an indication of which strain outcompeted the other.

The design of the experiment is as follows, observe aseptic technique throughout, 6803 refers to Synechocystis sp. PCC 6803:

  1. Add approx. 200ml of BG-11 medium to a sterile conical flask.
  2. Inoculate flask with 10µl of stock Wild type 6803, and 10µl of stock mutant 6803.
  3. Incubate flask in incubator on a shaker, at 58rpm and 30°C, under bright white light. Allow bacteria time to grow, monitoring the growth over time by observing the colour of the medium and by taking OD750 readings.
  4. Once the flask had reached a suitable cell density (e: g hundreds of millions of cells per ml), spread 1ml of culture over the surface of two plates, one of BG-11 and agar, and one which additionally contains the antibiotic Kanamycin (mutants should be marked with a Kanamycin resistance gene).
  5. Estimate the colony forming units per ml (cfu/ml) on each plate.
  6. The difference in cfu/ml on each plate will give an indication of which strain of 6803, wild type or mutant, will out-compete the other when placed in the same environment.

Ferricyanide assay to measure electron output of various strains of Synechocystis sp. PCC 6803

[Fe(CN)6]3- + e- ⇌ [Fe(CN)6]4-

  • Ferricyanide is a complex ion composed of an Fe3+ ion chelated by six CN- ions, which has an octahedral geometry, and a net charge of 3-.
  • Treatment of the ferricyanide ion with ferrous salts gives Prussian Blue (pigment)
  • Ferricyanide reduction measures activity of membraneous reductases
  • Ferricyanide oxidised by Fe3+ in the presence of Ferene-S (acidic conditions)
  • Chromogenic Ferene-S/Fe2+ complex is formed upon reduction, which has a net 4- charge.

Public perception and awareness study: Methods and Questionaire

References